China to boost credit support to consumer sector – regulator

BEIJING (Reuters) – China will guide banks to boost credit in the consumer service industry, its financial regulator said on Thursday, as authorities seek to boost a flagging post-pandemic economic recovery. “Residents’ consumption capacity is insufficient and their willingness to spend is not strong, consumption of big-ticket items is weak,” an official from China’s National…

Read More

Pakistan seen hiking rates again on IMF guidance, analysts say

By Ariba Shahid KARACHI (Reuters) – Pakistan’s central bank will likely raise its key interest rate again on Monday to tackle persistently high inflation, giving in to pressure from the International Monetary Fund (IMF), analysts said. Pakistan must continue its monetary tightening cycle, the International Monetary Fund (IMF) said in a staff report earlier in…

Read More

Norwegian woman, Nepali sherpa become world’s fastest to climb all 14 tallest peaks

By Gopal Sharma KATHMANDU (Reuters) – A Norwegian woman and her sherpa guide climbed Mount K2 in Pakistan on Thursday, their 14th highest mountain in just over three months, becoming the world’s fastest climbers to scale all peaks above 8,000 metre (26,246 feet) in the shortest time, an official of their Nepali organising company said….

Read More

Shell, TotalEnergies profits slump as oil, gas prices cool after bumper 2022

By Shadia Nasralla, Ron Bousso and America Hernandez LONDON/PARIS (Reuters) -Shell and TotalEnergies reported sharp falls in second-quarter profit from bumper 2022 earnings as oil and gas prices, refining margins and trading results all weakened. Oil and gas prices soared last year in the wake of Russia’s invasion of Ukraine but energy prices have dropped…

Read More

Japan’s Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine

TOKYO (Reuters) -Japan’s Takeda Pharmaceutical posted first-quarter profit that beat analysts’ estimates, citing solid sales of mainstay drugs and the launch of new products including its dengue fever vaccine. The result marked a better-than-expected start to a rebuilding year for Takeda, as main sellers lose patent protection and it works to wring new winners out…

Read More